Peggy Pinkston | VP, IR & Executive Director of Corporate Communications |
Clay Siegall | Chairman, President & CEO |
Robin Taylor | Chief Commercial Officer |
Todd Simpson | Chief Financial Officer |
Roger Dansey | Chief Medical Officer |
Michael Schmidt | Guggenheim Partners |
Kennen MacKay | RBC Capital Markets |
Salveen Richter | Goldman Sachs |
Gena Wang | Barclays |
Andrew Berens | SVB Leerink |
Andy Hsieh | William Blair |
Shanshan Xu | Berenberg Capital Markets |
Silvan Tuerkcan | Oppenheimer |
Tazeen Ahmad | Bank of America Merrill Lynch |
Chad Messer | Needham & Co. |
Good day, and welcome to the Seattle Genetics Third Quarter 2019 Financial Results Conference Call. Today's call is being recorded.
At this time, I would like to turn the conference over to Peggy Pinkston, Vice President of Investor Relations. Ma'am, please go ahead.
Thank you, operator, and good afternoon, everyone.